Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer withdraws sickle cell drug Oxbryta
Pfizer’s Sickle Cell Drug Candidates Not Hit by Oxbryta Pull
All data considered, the benefit of the therapy, Oxbryta, “no longer outweighs the risk,” Pfizer said in a statement Wednesday. The company, which also announced discontinuing clinical trials as it investigates the findings,
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
Pfizer to withdraw sickle cell treatment OXBRYTA from market
Pfizer has announced the withdrawal of all lots of OXBRYTA approved for treating sickle cell disease (SCD) from worldwide markets.
7h
on MSN
FDA alerts patients about Pfizer's Oxbryta withdrawal
The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of ...
GEN
1d
Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses 16 Deaths in Trials
Sixteen patients dosed with Pfizer’s sickle cell disease drug
Oxbryta
® (voxelotor) in a pair of clinical trials have died, ...
devdiscourse
7h
Current Updates: Major Developments in Health Sector
This summary highlights major health news, including Bavarian Nordic's UNICEF agreement for mpox vaccines, Pfizer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Counselor accused of assault
Seeks dismissal of charges
Stadiums to serve as shelters
Chinese submarine sank
Kotb leaving 'Today'
Military recruiting rebounds
Targeted Black residents?
On active shooter drills
To withdraw sickle cell drug
Disbarred in DC
NC board removes 747K
Arrives in Luxembourg
Jan. 6 report delayed
$8B military aid for Ukraine
US suicides steady, high
Rose announces retirement
Settles defamation lawsuit
WI duplicate ballot flap
ISR rejects ceasefire talks
NIH finds misconduct
Weekly jobless claims fall
Capital goods orders up
RU hits Ukraine's power grid
US economy grew
On Secret Service failures
More executives leave
Boxes to distribute Narcan
Urgent safety alert for 737s
50/50 ball ownership suit
Password-sharing crackdown
Related topics
Pfizer
Sickle cell disease
Food and Drug Administration
Feedback